IPPH
Isopropylphenidate
Also known as IPH · IPPD · IPP
Images
Quick reference
Duration
Experience
Primary effects
- Subtle, mind-only stimulation, promoting focus and clarity without significant physical effects or typical stimulant buzz.
- Mild effects, potentially requiring redosing for noticeable impact, lacking euphoria or a strong 'kick'.
Peak character
- Clear-headed and gentle, with a lack of typical stimulant euphoria or wired excitation, suitable for functional use.
- Not associated with jaw tension or pupil dilation, suggesting a less intense physical profile.
Negatives / side effects
- May disappoint those seeking an 'all-firing high' or wired experience, as effects are very subtle.
- Initial doses might be too weak, leading to re-dosing for desired effects; careful titration is advised.
Aftereffects / comedown
- Reported to have little 'residue-stim', allowing for sleep a few hours post-ingestion.
- Generally low 'body load' and no significant 'stim-dick' noted.
Reference dosage
Reference ranges from third-party harm-reduction databases. Individual response varies enormously — start lower than you think.
| threshold | 2mg+ |
| light | 5mg+ |
| common | 10mg+ |
| strong | 20mg |
| heavy | 35mg+ |
Reagent testing
| Mandelin | Yellow → orange |
| Marquis | Orange/brown |
Adulterant detection: Isopropylphenidate — methylphenidate analogue.
Methylphenidate-class. Limited specific reagent data; follow MPH protocol.
Source
Reference fields and narrative for IPPH extracted from The Drug Users Bible by Dominic Milton Trott (MxZero Publishing, 2022).
drugusersbible.comHarm reduction notice
This platform provides educational and harm-reduction information adapted from public reference material. It does not endorse, encourage, or facilitate drug use. It is not medical advice. If you or someone near you may be in a medical emergency, contact local emergency services immediately.